Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Psyence Group Inc.: Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein | 1 | GlobeNewswire (USA) | ||
18.03. | Psyence Biomed expands advisory board with psychopharmacology expert | - | Investing.com | ||
18.03. | Psyence Biomed erweitert Beirat mit Experten für Psychopharmakologie | 1 | Investing.com Deutsch | ||
18.03. | Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein | 218 | Newsfile | New York, New York--(Newsfile Corp. - March 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence Biomed" or the "Company") today announced that it has expanded and further strengthened its Scientific... ► Artikel lesen | |
10.03. | Psyence Group Inc.: Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board | 137 | GlobeNewswire (Europe) | TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM"... ► Artikel lesen | |
04.03. | Psyence Biomedical files to sell 13.81M common shares for holders | 1 | Seeking Alpha | ||
PSYENCE BIOMEDICAL Aktie jetzt für 0€ handeln | |||||
24.01. | PSYENCE BIOMEDICAL LTD. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
23.01. | PSYENCE BIOMEDICAL LTD. - 6-K, Report of foreign issuer | - | SEC Filings | ||
31.12.24 | PSYENCE BIOMEDICAL LTD. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
27.12.24 | Psyence Biomedical Ltd.: Psyence Biomed Announces Closing of $2.0 Million Private Placement | 2 | GlobeNewswire (USA) | ||
23.12.24 | PSYENCE BIOMEDICAL LTD. - 6-K, Report of foreign issuer | - | SEC Filings | ||
23.12.24 | Psyence Biomed announces $2 million private placement | 2 | Investing.com | ||
23.12.24 | Psyence Biomedical dips 18%, prices $2M offering | 1 | Seeking Alpha | ||
23.12.24 | Psyence Biomedical Ltd.: Psyence Biomed Announces $2.0 Million Private Placement | 1 | GlobeNewswire (USA) | ||
23.12.24 | Psyence Biomedical regains compliance with Nasdaq | 1 | Seeking Alpha | ||
23.12.24 | Psyence Biomedical Ltd.: Psyence Biomedical Regains Full Compliance with All Nasdaq Continued Listing Requirements | 179 | GlobeNewswire (Europe) | NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has received notice from the Nasdaq Hearings panel that... ► Artikel lesen | |
20.12.24 | PSYENCE BIOMEDICAL LTD. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
20.12.24 | Pre-market Movers: My Size, Nvni Group, Psyence Biomedical, Humacyte, PainReform | 679 | AFX News | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET).In the Green My Size, Inc. (MYSZ) is up over 372% at $6.43.
Nvni... ► Artikel lesen | |
18.12.24 | PSYENCE BIOMEDICAL LTD. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
17.12.24 | Optimi Health Corp: Optimi Health signs agreement with Psyence Biomedical | 3 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIOLINERX | 3,283 | -100,00 % | BioLineRx Q4 2024 Earnings Preview | ||
TRANSCODE THERAPEUTICS | 0,527 | +1,35 % | TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138 | First patient in Cohort four has been treated with TTX-MC138
Ten patients have been treated with TTX-MC138 at escalating dose levels
Additional patients being... ► Artikel lesen | |
SILEXION THERAPEUTICS | 1,160 | -1,69 % | Silexion Therapeutics Corp: Silexion Therapeutics Unveils Innovative Expanded Development Plan for SIL204 Based on Recent Groundbreaking Preclinical Data | Grand Cayman, Cayman Islands, March 28, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference... ► Artikel lesen | |
MINK THERAPEUTICS | 9,050 | +0,22 % | MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress | NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural... ► Artikel lesen | |
QIAGEN | 36,800 | -0,11 % | Biotech Report: Sektor unter Druck - Evotec verlieren, Qiagen behauptet | (shareribs.com) Frankfurt / New York 26.03.2025 - Biotechwerte tendierten im deutschen Handel schwächer, lediglich 4SC konnte leichte Kursgewinne verbuchen. An der Wall Street rutschte der Sektor ab.... ► Artikel lesen | |
TEMPUS AI | 47,480 | -8,64 % | Why Tempus AI Inc. (TEM) Crashed On Wednesday? | ||
EVOTEC | 6,000 | -1,23 % | Übernahmespekulationen und Kaufempfehlungen: Bayer, BioNTech, Evotec, BioNxt Solutions Aktie | Während bei Evotec derzeit die Übernahmespekulationen pausieren, nehmen sie bei BioNxt Solutions Fahrt auf. Das Unternehmen will in den kommenden 60 Tagen wichtige Meilensteine auf dem Weg zur Vermarktung... ► Artikel lesen | |
PORTAGE BIOTECH | 9,630 | +103,59 % | Pre-market Movers: Portage Biotech, XTI Aerospace, Marblegate Acquisition Corp., Cricut, Ecarx Holdings | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.25 A.M. ET).In the Green Portage Biotech Inc (PRTG) is up over 155% at $12.09.
Bowen... ► Artikel lesen | |
BIONTECH | 86,90 | -1,36 % | Bayer, Vidac Pharma, BioNTech - Niederschläge und neue Maßstäbe | Glyphosat und kein Ende. Die Übernahme des US-amerikanischen Agrarunternehmens Monsanto durch Bayer im Jahr 2018 entwickelt sich weiterhin zum Milliardengrab, erneut entschied ein Gericht gegen die... ► Artikel lesen | |
CUREVAC | 2,788 | +0,50 % | EQS-News: CureVac erhält positive Entscheidung zur Patentgültigkeit vom Europäischen Patentamt im Rechtsstreit mit BioNTech SE | Emittent / Herausgeber: CureVac
/ Schlagwort(e): Patent
CureVac erhält positive Entscheidung zur Patentgültigkeit vom Europäischen Patentamt im Rechtsstreit mit BioNTech SE
27.03.2025... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 5,785 | -3,10 % | Recursion Pharmaceuticals CEO verkauft Aktien im Wert von 836.986 US-Dollar | ||
SPRINGWORKS THERAPEUTICS | 47,040 | -1,45 % | SpringWorks Therapeutics, Inc.: SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates | - Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively - - Received FDA approval of GOMEKLI (mirdametinib)... ► Artikel lesen | |
BB BIOTECH | 32,650 | -2,25 % | BB Biotech Aktie: Gibt es jetzt Probleme? | Die BB Biotech AG kämpft aktuell mit einem erheblichen Wertverlust. Die Aktie notiert bei 31,85 CHF und hat innerhalb der letzten Woche einen Rückgang von 8,08% verzeichnet. Im Monatsvergleich fällt... ► Artikel lesen | |
STRYKER | 337,00 | +0,12 % | US-Militär verstärkt Grenzsicherung mit Stryker-Fahrzeugen | ||
ADMA BIOLOGICS | 20,110 | -0,74 % | How IBD Stock Of The Day ADMA Biologics Shrugged Off Accounting Debacle For A Bullish Comeback |